Rosiglitazone

Back to search

Molecule Structure

Scientific Name

Rosiglitazone

Description of the Drug

Rosiglitazone is a thiazolidinedione indicated as an adjunct to diet and exercise to maintain glycemic control in type 2 diabetes.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00412

Brand Name(s)

Avandia

Company Owner(s)

Teva Pharmaceuticals Usa Inc, Ani Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Sb Pharmco Puerto Rico Inc, Woodward Pharma Services Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Peroxisome proliferator-activated receptor gamma SINGLE PROTEIN AGONIST CHEMBL235

Unichem Links

Atlas rosiglitazone
SureChEMBL SCHEMBL5169
PharmGKB PA451283
Human Metabolome Database HMDB0005031
DrugBank DB00412
PubChem: Thomson Pharma 14876617
PubChem 77999
Mcule MCULE-8293284864
LINCS LSM-1949
Nikkaji J620.770G
BindingDB 50030474
EPA CompTox Dashboard DTXSID7037131
DrugCentral 2405
Brenda 83445 3404
ChemicalBook CB7133275
Guide to Pharmacology 1056
rxnorm AVANDIA ROSIGLITAZONE AVANDAMET ROSIGLITAZONE MALEATE
PubChem: Drugs of the Future 50086904
ChEBI 50122